SKIN

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

High

1.580

Open

1.500

VWAP

1.49

Vol

1.92M

Mkt Cap

185.21M

Low

1.380

Amount

2.86M

EV/EBITDA(TTM)

Total Shares

123.63M

401.70M

EV/OCF(TTM)

11.16

P/S(TTM)

0.68

The Beauty Health Company is a category-creating company that delivers beauty health experiences. Its flagship brand, HydraFacial, has created the category of hydra dermabrasion by using patented Vortex-Fusion Delivery Systems (Delivery Systems) to cleanse, extract, infuse, and hydrate the skin with solutions and serums. The Company has omnichannel place Delivery Systems where consumers live, work, and play, including medical offices, Medi spas, day spas, hotels, resorts, gyms, wellness centers, and other retail settings. HydraFacial is accessible and appropriate for consumers across all genders, ages, and skin types. It provides Keravive, which is a treatment designed to cleanse, exfoliate, and hydrate the scalp. HydraFacial is available in over 90 countries with an install base of approximately 25,000 Delivery Systems.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

77.29M

-7.44%

0.010

-150%

69.21M

-12.17%

-0.010

-122.99%

74.07M

-18.25%

-0.020

-124.48%

Estimates Revision

The market is revising Downward the revenue expectations for The Beauty Health Company (SKIN) for FY2025, with the revenue forecasts being adjusted by -14% over the past three months. During the same period, the stock price has changed by -11.98%.

Revenue Estimates for FY2025

Revise Downward

-14%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-11.98%

In Past 3 Month

6 Analyst Rating

-2.04% Downside

Wall Street analysts forecast SKIN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SKIN is 1.44 USD with a low forecast of 1.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

5 Hold

1 Sell

Hold

-2.04% Downside

Current: 1.470

Low

1.00

Averages

1.44

High

2.00

-2.04% Downside

Current: 1.470

Low

1.00

Averages

1.44

High

2.00

Canaccord Genuity

Susan Anderson

Hold

Maintains

$1.5 → $1.25

2025-05-05

Reason

Canaccord Genuity

Susan Anderson

Price Target

$1.5 → $1.25

2025-05-05

Maintains

Hold

Reason

Canaccord analyst Susan Anderson lowered the firm's price target on Beauty Health to $1.25 from $1.50 and keeps a Hold rating on the shares. The firm updated its model ahead of its quarterly results.

Canaccord Genuity

Susan Anderson

Hold

Maintains

$1.75 → $1.5

2025-03-13

Reason

Canaccord Genuity

Susan Anderson

Price Target

$1.75 → $1.5

2025-03-13

Maintains

Hold

Reason

Canaccord lowered the firm's price target on Beauty Health to $1.50 from $1.75 and keeps a Hold rating on the shares. The firm said they reported Q4 sales were lower and although the high- margin consumables business continues to perform well, we continue to see new machine placements severely pressured due to macro conditions.

Canaccord Genuity

Susan Anderson

Hold

Maintains

$1.25 → $1.75

2024-11-13

Reason

Canaccord Genuity

Susan Anderson

Price Target

$1.25 → $1.75

2024-11-13

Maintains

Hold

Reason

Canaccord raised the firm's price target on Beauty Health to $1.75 from $1.25 and keeps a Hold rating on the shares. The firm said the company has continued to see strong demand for the consumables business, with sales up around +10% while macro conditions have impacted new machine placements, leading to roughly 46% year-over-year decline in delivery system revenue.

Canaccord Genuity

Susan Anderson

Hold

Maintains

$2 → $1.25

2024-08-12

Reason

Canaccord Genuity

Susan Anderson

Price Target

$2 → $1.25

2024-08-12

Maintains

Hold

Reason

Piper Sandler

Korinne Wolfmeyer

Sell

Reiterates

$1.5 → $1

2024-08-09

Reason

Piper Sandler

Korinne Wolfmeyer

Price Target

$1.5 → $1

2024-08-09

Reiterates

Sell

Reason

Stifel

Jonathan Block

Hold

Maintains

$4 → $2

2024-07-26

Reason

Stifel

Jonathan Block

Price Target

$4 → $2

2024-07-26

Maintains

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Beauty Health Co (SKIN.O) is -22.00, compared to its 5-year average forward P/E of 71.21. For a more detailed relative valuation and DCF analysis to assess Beauty Health Co 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

71.21

Current PE

-22.00

Overvalued PE

229.80

Undervalued PE

-87.39

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

39.51

Current EV/EBITDA

60.62

Overvalued EV/EBITDA

86.31

Undervalued EV/EBITDA

-7.29

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

3.87

Current PS

0.81

Overvalued PS

7.57

Undervalued PS

0.16

Financials

Annual

Quarterly

FY2025Q1

YoY :

-14.52%

69.58M

Total Revenue

FY2025Q1

YoY :

-29.24%

-12.02M

Operating Profit

FY2025Q1

YoY :

+1386.89%

-10.10M

Net Income after Tax

FY2025Q1

YoY :

+700.00%

-0.08

EPS - Diluted

FY2025Q1

YoY :

-109.92%

1.85M

Free Cash Flow

FY2025Q1

YoY :

+17.52%

69.82

Gross Profit Margin - %

FY2025Q1

YoY :

+365.33%

9.26

FCF Margin - %

FY2025Q1

YoY :

+1648.19%

-14.51

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

22.0K

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

43.7K

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 87233.33% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

13.1M

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

22.0K

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

43.7K

USD

Months

SKIN News & Events

Events Timeline

2025-04-03 (ET)

2025-04-03

07:25:00

Elf Beauty, Helen of Troy exposed to China tariffs, says Canaccord

2025-03-12 (ET)

2025-03-12

16:31:59

Beauty Health sees FY25 revenue $270M - $300M , consensus $332.46M

2025-03-12

16:30:04

Beauty Health sees Q1 revenue $$61M - $66M , consensus $76M

News

9.5

05-09NASDAQ.COM

Beauty Health (SKIN) Reports Q1 Earnings: What Key Metrics Have to Say

7.0

05-08Globenewswire

Shareholder Alert: If You Are a Long-Term Holder of AppLovin Corporation (Nasdaq: APP); Maison Solutions, Inc. (Nasdaq: MSS); The Beauty Health Company (Nasdaq: SKIN); Or Virtu Financial Inc. (Nasdaq: VIRT) - Grabar Law Office Is Investigating Claims on Your Behalf

7.0

04-07Globenewswire

SKIN STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Investors to Contact the Firm